Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells

Pan, Feng, Wingo, Thomas S., Zhao, Zhigang, Gao, Rui, Makishima, Hideki, Qu, Guangbo, Lin, Li, Yu, Miao +20 more·2017·Nature Communications
DOI 10.1038/ncomms15102

Cited by (117)

Items 101–117 of 117

  1. Fine tuning of p53 functions between normal and leukemic cells: a new strategy for the treatment of chronic lymphocytic leukemia
    Tatjana Stanković · 2019 · Haematologica
  2. Genes and Mechanisms Responsible for Expansion of Acute Myeloid Leukaemia Blasts
    Michal Dvořák, M. Dvořáková · 2019 · Folia Biologica
  3. Pedigree Investigation, Clinical Characteristics and Prognosis Analysis of Hematological Disease Patients with Germline TET2 Mutation
    Xia Wu, Jili Deng, Nanchen Zhang, Xiaoyan Liu, Xue Zheng, Tianyou Yan, Ye Wu, Yuping Gong · 2021 · Research Square
  4. The interplay between DNA damage and epigenetics in cancer
    Dayna Challis, Kate H. Brettingham‐Moore · 2022 · Elsevier eBooks
  5. STING-dependent cytosolic DNA sensing pathway drives the progression to leukemia in TET2-mutated HSPCs
    Jiaying Xie, Mengyao Sheng, Shaoqin Rong, Chao Wang, Wanling Wu, Jingru Huang, Yue Sun, Pingyue Chen, Yushuang Wu, Yuanxian Wang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Data from TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors
    Silvia Maifrede, Bac Viet Le, Margaret Nieborowska-Skorska, Konstantin V. Golovine, Katherine Sullivan-Reed, Wangisa M.B. Dunuwille, Joseph Nacson, Michael Hulse, Kelsey Keith, Jozef Madžo et al. · 2023
  7. Data from PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation
    Maria M. Aivalioti, Boris Bartholdy, Kith Pradhan, Tushar Damodar Bhagat, Aliona Zintiridou, Jong Jin Jeong, Victor J. Thiruthuvanathan, Mario Andres Pujato, Aditi Paranjpe, Chi Zhang et al. · 2023
  8. Data from PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation
    Maria M. Aivalioti, Boris Bartholdy, Kith Pradhan, Tushar Damodar Bhagat, Aliona Zintiridou, Jong Jin Jeong, Victor J. Thiruthuvanathan, Mario Andres Pujato, Aditi Paranjpe, Chi Zhang et al. · 2023
  9. Etude du rôle et des modes d’action de l’enzyme épigénétique TET chez la drosophile
    Manon Boulet · 2021
  10. Physiopathological mechanisms leading to two congenital thrombocytopenias, congenital amegakaryocytic thrombocytopenia (CAMT) and thrombocytopenia 2 (THC2)
    Francesca Basso‐Valentina · 2021 · theses.fr (ABES)
  11. Chimiorésistance et implications pronostiques de l'expression et de l'épissage alternatif du transporteur ABCA3 dans les leucémies aiguës myéloïdes
    Antony Ceraulo · 2021
  12. Etude de l'hétérogénéité du microenvironnement et des cellules tumorales dans le lymphome TFH
    Diana Laure Mboumba · 2024
  13. Rôle du dosage des facteurs de transcription dans l'initiation des leucémies aiguës mégacaryoblastiques pédiatriques par la fusion ETO2-GLIS2
    Marie Baille · 2024 · theses.fr (ABES)
  14. Rôle de TET2 dans la différenciation terminale des lymphocytes B et implication dans la lymphomagenèse B
    Michaël Degaud · 2023
  15. In vitro characterization of aberrant and futile DNA repair initiated by human Thymine-DNA glycosylase
    Diana Manapkyzy · 2024
  16. Modeling Chronic Myelomonocytic Leukemia with the Aim of Identifying Novel Therapeutic Targets
    Dana Alawieh · 2025 · theses.fr (ABES)
  17. Critical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case Report
    Stejara Nicoleta Mihai, Laura Denisa Dragu, Cristina Mambet, Anca Botezatu, Petruta Gurban, Laura Georgiana Necula, Lilia Matei, Ana Iulia Neagu, Ioana Mădălina Pitica, Marius Ataman et al. · 2026 · International Journal of Molecular Sciences